EOS Capital Partners announces the successful completion of the final closing phase of capital raising for the EOS Hellenic Renaissance Fund II (“EHRF II”). This is a private equity investment fund that invests in Greek small-to-medium enterprises and MidCaps – companies in growth phase with annual turnover up to €100 million and up to 500 employees, substantially strengthening entrepreneurship in strategic and export-oriented sectors of the Greek economy. The fund manager of EHRF II is EOS Capital Partners AIFM (“EOS Capital Partners”), a company licensed and supervised by the Hellenic Capital Market Commission.
EHRF II investments
The investors of EHRF II consist of 75% top domestic and international institutional investors, including the Hellenic Development Bank of Investments, and 25% prominent Greek entrepreneurs and family offices.
EHRF II has already made investments in four dynamically developing and export-oriented companies, including EFA Group, Pharma Koukaki, Megas Gyros and Seneca Medical Group. The EOS team is actively working on an ambitious investment program for 2026 and the following years.
“Commitment to invest, together with strong partners, in companies with exceptional prospects”
Apostolos Tamvakakis, Managing Partner of EOS Capital Partners, stated: “The successful completion of the final closing of EHRF II at the target level of €250 million confirms our unique position in the country’s business ecosystem. At the same time, it underlines our commitment to invest, together with strong partners, in companies with exceptional prospects.
We warmly thank both our existing and new investors for their continued support. We will make every possible effort to live up to their trust”.
